Fig. 4: NCS scores from the alcohol vs non-alcohol contrast as predictor of survival to relapse to heavy alcohol use. | Neuropsychopharmacology

Fig. 4: NCS scores from the alcohol vs non-alcohol contrast as predictor of survival to relapse to heavy alcohol use.

From: The neurobiological cravings signature (NCS) as a predictive neuromarker of clinical outcomes in alcohol use disorder

Fig. 4: NCS scores from the alcohol vs non-alcohol contrast as predictor of survival to relapse to heavy alcohol use.

A Kaplan-Meyer plot of time to relapse to heavy alcohol use ( > 60 g/day) during the 12 weeks following the post-treatment fMRI session, stratified by NCS group (High NCS: >3.37, dashed line, n = 20; Low NCS: ≤3.37, solid line, n = 19). All NCS scores are from the alcohol vs non-alcohol contrasts. B ROC analysis showing the discriminative performance of NCS applied to the alcohol vs non-alcohol contrast to identify cases of relapse. Dashed diagonal line representing AUC of 0.5 for reference.

Back to article page